Ebselen, a new candidate therapeutic against SARS-CoV-2
Authors:
- 1 December 2020
- journal article
- letter
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 84, 53-56
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Ebselen, a Small-Molecule Capsid Inhibitor of HIV-1 ReplicationAntimicrobial Agents and Chemotherapy, 2016
- Apocynin and ebselen reduce influenza A virus-induced lung inflammation in cigarette smoke-exposed miceScientific Reports, 2016
- Coronaviruses — drug discovery and therapeutic optionsNature Reviews Drug Discovery, 2016
- Effect of the Putative Lithium Mimetic Ebselen on Brain Myo-Inositol, Sleep, and Emotional Processing in HumansNeuropsychopharmacology, 2015
- Ebselen Attenuates Lung Injury in Experimental Model of Carrageenan-Induced Pleurisy in RatsInflammation, 2015
- Ebselen Inhibits Hepatitis C Virus NS3 Helicase Binding to Nucleic Acid and Prevents Viral ReplicationACS Chemical Biology, 2014
- The early research and development of ebselenBiochemical Pharmacology, 2013
- Ebsulfur Is a Benzisothiazolone Cytocidal Inhibitor Targeting the Trypanothione Reductase of Trypanosoma bruceiJournal of Biological Chemistry, 2013
- Ebselen Lowers Plasma Interleukin-6 Levels and Glial Heme Oxygenase-1 Expression after Focal Photothrombotic Brain IschemiaArchives of Biochemistry and Biophysics, 2000
- Antimalarial properties of ebselenParasitology Research, 1989